StockData
Silo Pharma, Inc. logo

Silo Pharma, Inc. (SILO) shareholders

SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.71+0.14 (+8.57%)

Close on Nov 17, 2026Market cap $2.72MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
9.0%
0M of 2M shares
Institutional holders
8
8 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
6 buys · 0 sales
Net bought $7.66K

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Tony Moore
Joint filing with Anson Funds Management LP (7.20%), Anson Management GP LLC (7.20%) and 3 more
952,3817.20%13G (passive)Sep 30, 2025
Intracoastal Capital LLC
Joint filing with Mitchell P. Kopin (9.99%), Daniel B. Asher (9.99%)
838,0819.99%13G (passive) amendmentJun 30, 2025
Renaissance Technologies Holdings Corporation
Joint filing with Renaissance Technologies LLC (5.06%)
227,0065.06%13G (passive)Sep 4, 2024
Mitchell P. Kopin
Joint filing with Daniel B. Asher (9.99%), Intracoastal Capital LLC (9.99%)
176,1659.99%13G (passive) amendmentSep 30, 2026
Daniel B. Asher
Joint filing with Mitchell P. Kopin (9.99%), Intracoastal Capital LLC (9.99%)
125,2619.99%13G (passive) amendmentJun 30, 2026
AdvisorShares Trust75,5826.69%13G (passive)Jun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of SILOValueChange% of portfolio
AdvisorShares Investments LLC75,5824.76%$469.36KNew0.06%
FNY Investment Advisers, LLC37,5072.36%$232.00KNew0.08%
Citadel Advisors LLC16,8001.06%$104.33KNew0.00%
Vanguard Capital Management LLC11,9560.75%$74.25KNew0.00%
Vanguard Fiduciary Trust Co8740.06%$5.43KNew0.00%
Tower Research Capital LLC (TRC)1810.01%$1.12KNew0.00%
Harbour Investments, Inc.140.00%$87New0.00%
Citigroup Inc10.00%$6New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202680M9.0%8 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

5 funds held SILO in Q1 2026, 88% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of SILOValue% of fundAs of
AdvisorShares Psychedelics ETF75,5824.76%$469.36K1.06%Jun 30, 2026
Vanguard Extended Market Index Fund11,9560.75%$74.25K0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Eric WeisblumChief Executive Officer, Director214,43213.50%Dec 16, 2025
Daniel E. RyweckChief Financial Officer5,0000.31%May 27, 2025
Wayne LinsleyDirector––May 27, 2025
Kevin MunozDirector––May 27, 2025
Jeff PavellDirector––May 27, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Eric Weisblum
Chief Executive Officer, Director
Dec 15, 2025Buy+2,500$0.41$1.03K214,432
Eric Weisblum
Chief Executive Officer, Director
Dec 15, 2025Buy+2,500$0.42$1.05K216,932
Eric Weisblum
Chief Executive Officer, Director
Nov 21, 2025Buy+1,000$0.37$370211,932
Eric Weisblum
Chief Executive Officer, Director
Nov 20, 2025Buy+1,000$0.37$370210,932
Eric Weisblum
Chief Executive Officer, Director
Nov 19, 2025Buy+4,500$0.41$1.85K209,932
Eric Weisblum
Chief Executive Officer, Director
Nov 18, 2025Buy+7,500$0.40$3.00K205,432
Eric Weisblum
Chief Executive Officer, Director
May 27, 2025Buy+10,000$0.43$4.30K197,932
Eric Weisblum
CEO and President, Director
Dec 13, 2024Buy+2,500$0.84$2.10K187,932
Eric Weisblum
CEO and President, Director
Nov 22, 2024Buy+2,500$0.90$2.25K185,432
Eric Weisblum
CEO and President, Director
Nov 20, 2024Buy+2,500$0.95$2.38K182,932
Eric Weisblum
CEO and President, Director
Jun 12, 2024Buy+4,438$1.11$4.93K180,432
Eric Weisblum
CEO and President, Director
Jun 11, 2024Buy+562$1.08$607175,994
Eric Weisblum
CEO and President, Director
Apr 5, 2024Buy+400$2.03$812175,432
Eric Weisblum
CEO and President, Director
Apr 4, 2024Buy+600$1.96$1.18K175,032
Eric Weisblum
CEO and President, Director
Apr 1, 2024Buy+1,100$1.91$2.10K174,432
Eric Weisblum
CEO and President, Director
Mar 28, 2024Buy+3,408$1.94$6.61K173,332
Eric Weisblum
CEO and President, Director
Dec 20, 2023Buy+200$1.61$322169,924
Eric Weisblum
CEO and President, Director
Dec 19, 2023Buy+500$1.63$815169,724
Eric Weisblum
CEO and President, Director
Dec 15, 2023Buy+900$1.52$1.37K169,224
Eric Weisblum
CEO and President, Director
Dec 14, 2023Buy+200$1.50$300168,324
Eric Weisblum
CEO and President, Director
Dec 7, 2023Buy+324$1.36$441168,124
Eric Weisblum
CEO and President, Director
Dec 6, 2023Buy+76$1.34$102167,800
Eric Weisblum
CEO and President, Director
Dec 5, 2023Buy+600$1.39$834167,724
Eric Weisblum
CEO and President, Director
Nov 30, 2023Buy+1,000$1.53$1.53K167,124
Eric Weisblum
CEO and President, Director
Nov 29, 2023Buy+1,000$1.57$1.57K166,124
Eric Weisblum
CEO and President, Director
Nov 27, 2023Buy+250$1.78$445165,124
Eric Weisblum
CEO and President, Director
Nov 22, 2023Buy+400$1.68$672164,874
Eric Weisblum
CEO and President, Director
Nov 21, 2023Buy+300$1.56$468164,474
Eric Weisblum
CEO and President, Director
Nov 20, 2023Buy+4,050$1.60$6.48K164,174
Eric Weisblum
CEO and President, Director
Nov 17, 2023Buy+1,800$1.54$2.77K160,124
Eric Weisblum
CEO and President, Director
Nov 16, 2023Buy+1,100$1.33$1.46K158,324
Daniel E. Ryweck
Chief Financial Officer
May 26, 2023Buy+1,000$2.13$2.13K5,000
Eric Weisblum
CEO and President, Director
May 18, 2023Buy+500$2.11$1.06K157,724
Eric Weisblum
CEO and President, Director
May 17, 2023Buy+2,500$2.06$5.15K157,224
Eric Weisblum
CEO and President, Director
Dec 20, 2022Buy+130$2.72$354154,854
Eric Weisblum
CEO and President, Director
Dec 19, 2022Buy+200$2.68$536154,724
Eric Weisblum
CEO and President, Director
Dec 14, 2022Buy+263$3.17$834154,524
Eric Weisblum
CEO and President, Director
Dec 13, 2022Buy+487$3.07$1.50K154,261
Eric Weisblum
CEO, CFO and President, Director
Jun 17, 2022Buy+13,080$0.11$1.44K7,724,643
Eric Weisblum
Chief Executive Officer, Director
Dec 13, 2021Buy+17,500$0.14$2.45K7,711,563
Eric Weisblum
Chief Executive Officer, Director
Dec 10, 2021Buy+5,000$0.16$8007,694,063
Eric Weisblum
CEO, CFO and President, Director
Apr 28, 2020Award+7,630,949––7,689,063
Eric Weisblum
CHIEF EXECUTIVE OFFICER, Director
Apr 17, 2020Award+7,630,949––7,988,663
Eric Weisblum
CEO, CFO and President, Director
Oct 22, 2019Buy+200$0.45$9058,114
Eric Weisblum
CEO, CFO and President, Director
Oct 15, 2019Buy+200$0.38$7657,914
Eric Weisblum
CEO, CFO and President, Director
Jun 17, 2019Buy+57,714––57,714
Eric Weisblum
Pres, Chief Compliance Officer, Director
Sep 4, 2014Gift−3,584,160$1.00$3.58M0
Van Eps Parker
Director
Jul 30, 2014Award+37,500––37,500
Eric Weisblum
President and CCO, Director
Jun 20, 2013Award+3,584,160––3,584,160
Richard Brand
Chairman and CEO, Director
Jun 20, 2013Award+2,042,080––2,042,080

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
1.01%
0M shares short
Days to cover
1.1
At 0M shares a day
Change since last report
-37.6%
From 0M shares
Short volume, 20 days
36.1%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Silo Pharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 15,448 shares on Sep 21, 2026 over the last 90 days.

See a number that looks wrong?